X

Ahlcon Parenterals (India) Ltd Stock Analysis

Small Cap
Evaluated by 161 users | BSE: 524448 | NSE: |
Pharmaceuticals & Drugs
Ahlcon Parenterals (India), incorporated in 1992, is engaged in manufacturing life saving Intravenous fluids and medical disposals by employing a highly sophisticated production process, the aseptic form-fill-seal technology imported from Switzerland.Ahlcon has an installed capacity of 30...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Return on Capital Employed 17.68%8.3%19.07%11.29%11.5%21.5%21.81%8.8%-0.72%1.12%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 45.837.850.362.479.7108120116119135
Y-o-Y Gr. Rt.--17.4%32.9%24.1%27.7%35.1%11.4%-3.3%2.6%13.8%
Adjusted EPS (Rs.) 8.423.289.966.076.6317.6627.0824.6-19.2-11.75
Y-o-Y Gr. Rt.--61.1%203.7%-39.1%9.2%166.4%53.3%-9.2%-178.1%NA
Book Value per Share (Rs.) 38.1239.4447.5451.6757.3675.12102.14124.7599.0179.81
Adjusted Net Profit 6.12.47.24.44.812.719.517.7-13.8-8.5
Net Op. Cash Flow (Rs. Cr.) 75.88.838.59.317.131.27.812.7
Debt to Cash Flow from Ops 2.582.251.148.212.71.862.526.6232.1321.49
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Ahlcon Parenterals (India) Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 12.8%11.2%4.1%13.8%
Adjusted EPS -203.8%-212.1%-175.7%NA
Book Value per Share 8.66.8-7.9-19.4
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17
Return on Equity (%) 22.478.222.2511.9311.8926.1730.3521.69-17.17-13.14
Operating Profit Margin (%) 29.0417.7629.0318.216.8222.9128.7323.0512.6119.78
Net Profit Margin (%) 13.246.2514.2675.9911.8116.2615.27-11.62-6.25
Debt to Equity 0.640.440.290.650.540.320.592.33.524.76
Working Capital Days 107181143125123107122149152140
Cash Conversion Cycle 1561506460556786103101
Entity Percentage Holding
Promoters 93.26%
Non-Institutions 6.74%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Ahlcon Parenterals (India), incorporated in 1992, is engaged in manufacturing life saving Intravenous fluids and medical disposals by employing a highly sophisticated production process, the aseptic form-fill-seal technology imported from Switzerland.

Ahlcon has an installed capacity of 30 million bottles per annum for LVP in pack size of 100ml and 500ml. Further, 200ml and 300ml packs are being launched in near future.

The company also has capacity of 60 million vials of eye drops and

Ahlcon Parenterals (India), incorporated in 1992, is engaged in manufacturing life saving Intravenous fluids and medical disposals by employing a highly sophisticated production process, the aseptic form-fill-seal technology imported from Switzerland.

Ahlcon has an installed capacity of 30 million bottles per annum for LVP in pack size of 100ml and 500ml. Further, 200ml and 300ml packs are being launched in near future.

The company also has capacity of 60 million vials of eye drops and injections in the fill size of 2ml, 3ml, 5ml & 10ml both in transparent and white opaque packs as SVP.

Within a short span of time since its inception, the company has achieved the quality certification from WHO-GMP International and ISO 9002, a landmark achievement which ensures international quality standards with ultimate objective of getting the MCA approval.

Products

Antimicrobial I V fluids, eye and ear drops, ointments, other products such as respiratory solutions, plasma volume expander and many more.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback